Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.
To investigate pathways of human esophageal squamous cell transformation, we generated esophageal tumor cells using human telomerase- and SV40-immortalized primary esophageal epithelial cells (EPC2) by overexpression of selected combinations of oncogenes. H-Ras, c-Myc, or Akt, but not epidermal growth factor receptor (EGFR), induced transformed colonies in soft agar. By contrast, bioluminescence imaging of genetically altered immortalized esophageal cells revealed that Akt, EGFR, or H-Ras, but not c-Myc, resulted in tumor formation in immunodeficient mice. H-Ras-driven tumors showed highly tumorigenic phenotypes with 2.6 +/- 0.6 days for doubling, whereas Akt and EGFR tumors doubled every 9.5 +/- 1.6 and 6.1 +/- 1.2 days, respectively. H-Ras-driven tumors expressed the hypoxia-inducible factor target Glut1, whereas Akt- or EGFR-driven tumors had evidence of angiogenesis and no detectable Glut1 expression. Proliferation rates among these tumors were similar, but there was reduced apoptosis in the more aggressive H-Ras-driven tumors that also developed aneuploidy and multiple centrosomes. c-Myc overexpression did not result in tumorigenic conversion but introduction of Bcl-XL into c-Myc-expressing cells generated tumors. Although cytokeratin expression was typical of squamous carcinoma, gene expression profiling was done to compare the four different types of engineered tumors with human esophageal squamous cell carcinomas and adenocarcinomas. Interestingly, c-Myc plus Bcl-XL transformants mimicked squamous carcinomas, whereas H-Ras-, EGFR-, and Akt-driven tumors were similar to adenocarcinomas in their molecular profiles. These genetically engineered models may provide new platforms for understanding human esophagus cancer and may assist in the evaluation of new therapies.
Kim
Seok-Hyun
SH
Laboratory of Molecular Oncology and Cell Cycle Regulation, Department of Medicine (Hematology/Oncology), University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Nakagawa
Hiroshi
H
Navaraj
Arunasalam
A
Naomoto
Yoshio
Y
Klein-Szanto
Andres J P
AJ
Rustgi
Anil K
AK
El-Deiry
Wafik S
WS
D000782:Aneuploidy; D000818:Animals; D002461:Cell Line, Transformed; D002471:Cell Transformation, Neoplastic; D004847:Epithelial Cells / Q000473:pathology; D066246:ErbB Receptors / Q000235:genetics; D004938:Esophageal Neoplasms / Q000209:etiology*; D020869:Gene Expression Profiling; D016259:Genes, myc; D011905:Genes, ras; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D009368:Neoplasm Transplantation; D009857:Oncogenes; D051057:Proto-Oncogene Proteins c-akt / Q000235:genetics; D014183:Transplantation, Heterologous; D051020:bcl-X Protein / Q000032:analysis
D051020:bcl-X Protein; D066246:ErbB Receptors; D051057:Proto-Oncogene Proteins c-akt